Treace Medical Concepts annual depreciation and amortization
2019
2020
2021
2022
2023
2024
2025
Treace Medical Concepts Depreciation & Amortization Growth & History (TMCI)
Treace Medical Concepts's depreciation and amortization was $10.6M for fiscal 2025.
View full Treace Medical Concepts company overviewTreace Medical Concepts annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $10.6M | $2.2M | +26.18% |
| 2024 | 2024-12-31 | $8.4M | $3.1M | +57.31% |
| 2023 | 2023-12-31 | $5.4M | $3.2M | +150.91% |
| 2022 | 2022-12-31 | $2.1M | $1.4M | +211.39% |
| 2021 | 2021-12-31 | $685,000 | −$525,000 | −43.39% |
| 2020 | 2020-12-31 | $1.2M | $417,000 | +52.59% |
| 2019 | 2019-12-31 | $793,000 | — | — |
Treace Medical Concepts quarterly depreciation and amortization
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.9M | −$688,000 | −26.71% |
| Q1 2026 | 2026-03-31 | $899,000 | −$1.6M | −63.47% |
| Q4 2025 | 2025-12-31 | $2.8M | — | — |
| Q3 2025 | 2025-09-30 | $2.8M | $621,000 | +28.79% |
| Q2 2025 | 2025-06-30 | $2.6M | $460,000 | +21.74% |
| Q1 2025 | 2025-03-31 | $2.5M | $552,000 | +28.92% |
| Q3 2024 | 2024-09-30 | $2.2M | $593,000 | +37.92% |
| Q2 2024 | 2024-06-30 | $2.1M | $1.0M | +92.36% |
| Q1 2024 | 2024-03-31 | $1.9M | $985,000 | +106.60% |
| Q3 2023 | 2023-09-30 | $1.6M | $1.2M | +291.00% |
| Q2 2023 | 2023-06-30 | $1.1M | $700,000 | +175.00% |
| Q1 2023 | 2023-03-31 | $924,000 | $590,000 | +176.65% |
| Q3 2022 | 2022-09-30 | $400,000 | $200,000 | +100.00% |
| Q2 2022 | 2022-06-30 | $400,000 | $300,000 | +300.00% |
| Q1 2022 | 2022-03-31 | $334,000 | $217,000 | +185.47% |
| Q3 2021 | 2021-09-30 | $200,000 | −$100,000 | −33.33% |
| Q2 2021 | 2021-06-30 | $100,000 | −$300,000 | −75.00% |
| Q1 2021 | 2021-03-31 | $117,000 | −$187,000 | −61.51% |
| Q3 2020 | 2020-09-30 | $300,000 | — | — |
| Q2 2020 | 2020-06-30 | $400,000 | — | — |
| Q1 2020 | 2020-03-31 | $304,000 | — | — |
Treace Medical Concepts depreciation and amortization trends
Over the last five fiscal years, Treace Medical Concepts's depreciation and amortization increased from $1.2M to $10.6M, a change of $9.4M. The latest reported quarter, Q2 2026, shows $1.9M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Treace Medical Concepts source filings ↗